Downland Low Volume Calcium Solution for Injection

Țară: Regatul Unit

Limbă: engleză

Sursă: VMD (Veterinary Medicines Directorate)

Ingredient activ:

Boric Acid, Calcium, Magnesium

Disponibil de la:

Norbrook Laboratories Limited

Codul ATC:

QA12AA20

INN (nume internaţional):

Boric Acid, Calcium, Magnesium

Forma farmaceutică:

Solution for injection

Tip de prescriptie medicala:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupul Terapeutică:

Cattle

Zonă Terapeutică:

Mineral deficiency

Statutul autorizaţiei:

Expired

Data de autorizare:

2005-08-03

Caracteristicilor produsului

Revised: September 2010
AN: 00348/2010
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Downland Low Volume Calcium Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE(S)
Each 100 ml contains 4.2g calcium (provided by calcium gluconate,
calcium borogluconate and calcium hydroxide) and 0.78g magnesium
(provided by magnesium chloride hexahydrate). Also contains 7.34%
w/v boric acid.
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for Injection.
A clear, colourless to pale yellow solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Indicated in the treatment of hypocalcaemia in cattle complicated by a
deficiency of magnesium.
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In cases of acute hypomagnesaemia the administration, by appropriate
routes, of a solution with a higher concentration of magnesium may be
necessary.
Revised: September 2010
AN: 00348/2010
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The product does not contain an antimicrobial preservative. Any
solution remaining in the vial following withdrawal of required dose
should be discarded.
Solutions for intravenous injection should be warmed to body
temperature and infused slowly.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Care should be taken to avoid accidental self-injection: may cause
irritation at site of injection.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Rapid intravenous injection may result in cardiac arrythmias and in
severely toxaemic cows, collapse and death.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Provided the above precautions are observed the product should be
safe for use during pregnancy and lactation.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None recorded.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATIO